Karen Flynn
CIK 1553599 · Chief Commercial Officer · last filed 2026-05-27
Karen Flynn is a Chief Commercial Officer who has filed 97 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing, for SHC, was dated May 27, 2026. Across all open-market trades the lifetime net is −$5.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.05M
5
97
-$5.84M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SHC | Director | 54,191 | $16.19 | $877.4K | $0 | 3 | 2026-05-27 |
| QTRX | Director | 57,212 | $3.10 | $177.4K | $0 | 7 | 2026-01-06 |
| Catalent, Inc. (CTLT) Delisted | Chief Commercial Officer | 24,339 | $63.48 | $1.55M | -$577.0K | 10 | 2023-10-31 |
| Societal CDMO, Inc. (REPH) Delisted | Director | 39,283 | $2.09 | $82.1K | $5.4K | 9 | 2019-12-16 |
| WEST PHARMACEUTICAL SERVICES INC (WSTw) Delisted | Sr VP & Chief Commercial Offic | 24,989 | — | — | -$5.27M | 68 | 2019-02-21 |
Recent Filings
97 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-27 | SHC | Grant (A) | +14,970 | $0 | EDGAR |
| 2026-01-06 | QTRX | Grant (A) | +23,372 | $0 | EDGAR |
| 2025-05-27 | SHC | Grant (A) | +19,132 | $0 | EDGAR |
| 2025-01-06 | QTRX | Grant (A) | +7,435 | $0 | EDGAR |
| 2024-05-29 | SHC | Grant (A) | +20,089 | $0 | EDGAR |
| 2024-01-04 | QTRX | Grant (A) | +2,947 | $0 | EDGAR |
| 2023-10-31 | Catalent, Inc. (CTLT) Delisted | Grant (A) | +6,993 | $0 | EDGAR |
| 2023-01-04 | QTRX | Grant (A) | +9,001 | $11.8K | EDGAR |
| 2022-10-31 | Catalent, Inc. (CTLT) Delisted | Grant (A) | +4,149 | $0 | EDGAR |
| 2022-10-05 | QTRX | Grant (A) | +1,066 | $11.2K | EDGAR |